Fears of another wave of the COVID-19 pandemic looming on the horizon are taking shape even before the first wave in the U.S. has been contained, and investors are arguably concerned about what stocks they should hold on to during this difficult period. Indeed, the S&P 500 sold off nearly 6% on June 10 as these fears began to materialize.
Cannabis companies may be enticing ideas for investors worried about the current market. During this difficult time, many adults in the U.S. and Canada are turning to cannabis to deal with stress, anxiety, and boredom associated with lockdown and quarantine measures. Today, we'll look at which of the two leading companies in the marijuana sector, Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY), is a better buy right now.
Image source: Getty Images.
Source Fool.com